A new review co-authored with Dr. Urszala Kozlowska on psychedelics and neuroinflammation and neurodegeneration https://t.co/F1FbNMFbPB
From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Sep 2021 – Jul 2025Where it's discussed
-
X / Twitter19 posts
-
News4 articles
-
Blogs3 articles
-
YouTube2 videos
AI synopsis
What people are saying
Overall, the discussions demonstrate genuine interest and supportive attitudes toward the therapeutic prospects of psychedelics in neurology, using phrases like 'highlighted ability,' 'neuroinflammation and neurodegeneration,' and references to new reviews. The tone conveys both curiosity and optimism, indicating the article's significance to ongoing scientific discourse.
Most discussions express support or curiosity about the potential of psychedelics as therapeutic tools, highlighting promising research findings.
The discussions show a high level of interest, with many posts referencing new reviews, research insights, and potential clinical implications.
Posts reflect moderate engagement by citing specific studies and offering commentary, but lack deep analysis or critical debate.
The posts suggest that the article has a noteworthy influence, inspiring further research and raising awareness in the scientific community.
Abstract in brief
- Recent research shows that psychedelics like psilocybin can significantly improve symptoms of depression with just one treatment, leading to their potential approval for psychiatric use.
- Beyond mental health, studies suggest psychedelics might also help treat brain injuries and neurodegenerative diseases like Alzheimer's by promoting neuroplasticity, cell growth, and reducing inflammation.
- While promising, the exact molecular processes through which psychedelics exert these therapeutic effects are still being studied, especially how they influence interactions between neural and glial cells in the brain.
Top posts
Most liked on X and BlueskyFrom Psychiatry to Neurology: Psychedelics as Prospective Therapeutics for Neurodegenerative Disorders https://t.co/tzRMs1M1rR
From Psychiatry to Neurology: #Psychedelics as Prospective Therapeutics for Neurodegenerative Disorders 1/5 https://t.co/GcFYTKPXut
RT @APRA_bot: From Psychiatry to Neurology: Psychedelics as Prospective Therapeutics for Neurodegenerative Disorders https://t.co/tzRMs1M1rR
RT @APRA_bot: From Psychiatry to Neurology: Psychedelics as Prospective Therapeutics for Neurodegenerative Disorders https://t.co/tzRMs1M1rR
All mentions
Therapeutic Potential of Microdosing Psychedelics in Depression
This video explores the therapeutic potential of microdosing psychedelics in treating depression. It highlights recent studies and discusses implications for mental health. The information is drawn from various…
Neuroplasticity Induced by Psychedelics: Insights and Implications
Luke Thomas discusses the role of psychedelics in neuroplasticity and their potential therapeutic benefits for various psychiatric conditions. Learn about the neuropharmacology involved and how substances like…
From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders - PubMed https://t.co/uWyBfIme3D
@sustaipal @Psilocybenn @amaldorai @ashleevance “Preclinical work has highlighted psychedelics' ability to induce neuroplasticity and synaptogenesis, and neural progenitor cell proliferation. Psychedelics may also act as immunomodulators by reducing levels of proinflammatory biomarkers…” https://t.co/W98ClqwBvF
I just posted "Research {Data}:
RT @ViewsOnDrugsBot: From Psychiatry to Neurology: #Psychedelics as Prospective Therapeutics for Neurodegenerative Disorders 1/5 https://t…
From Psychiatry to Neurology: #Psychedelics as Prospective Therapeutics for Neurodegenerative Disorders 1/5 https://t.co/GcFYTKPXut
RT @lab_nichols: A new review co-authored with Dr. Urszala Kozlowska on psychedelics and neuroinflammation and neurodegeneration https://t.…
RT @lab_nichols: A new review co-authored with Dr. Urszala Kozlowska on psychedelics and neuroinflammation and neurodegeneration https://t.…
RT @lab_nichols: A new review co-authored with Dr. Urszala Kozlowska on psychedelics and neuroinflammation and neurodegeneration https://t.…
RT @lab_nichols: A new review co-authored with Dr. Urszala Kozlowska on psychedelics and neuroinflammation and neurodegeneration https://t.…
A new review co-authored with Dr. Urszala Kozlowska on psychedelics and neuroinflammation and neurodegeneration https://t.co/F1FbNMFbPB
RT @APRA_bot: From Psychiatry to Neurology: Psychedelics as Prospective Therapeutics for Neurodegenerative Disorders https://t.co/tzRMs1M1rR
RT @APRA_bot: From Psychiatry to Neurology: Psychedelics as Prospective Therapeutics for Neurodegenerative Disorders https://t.co/tzRMs1M1rR
RT @APRA_bot: From Psychiatry to Neurology: Psychedelics as Prospective Therapeutics for Neurodegenerative Disorders https://t.co/tzRMs1M1rR
From Psychiatry to Neurology: Psychedelics as Prospective Therapeutics for Neurodegenerative Disorders https://t.co/V4nXc1lZoR
From Psychiatry to Neurology: Psychedelics as Prospective Therapeutics for Neurodegenerative Disorders https://t.co/tzRMs1M1rR
New article: From Psychiatry to Neurology: Psychedelics as Prospective Therapeutics for Neurodegenerative Disorders https://t.co/mNpt92hgSu #alzheimers #neurology https://t.co/u5beJjqTRx